HIMV LLC – Trademark Portfolio

Entity Type: 16

HIMV LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include DPX, IMV, SPAYVAC, and IMV IMMUNOVACCINE. The owner is based in FARMINGTON, CT.

312 FARMINGTON AVENUE

FARMINGTON, CT 06032

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DPX
DPX
Registered 2018
IMV
IMV
Registered 2018
VACCIMAX
VACCIMAX
Cancelled 2002
SPAYVAC
SPAYVAC
Registered 2001

Trademark Classifications

HIMV LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does HIMV LLC have?

HIMV LLC has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 cancelled.

What trademark classes does HIMV LLC file in?

HIMV LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are HIMV LLC's most well-known trademarks?

HIMV LLC's registered trademark portfolio includes well-known marks such as DPX, IMV, SPAYVAC, and IMV IMMUNOVACCINE. These are among 4 currently registered trademarks in the portfolio.

What is HIMV LLC's trademark registration success rate?

HIMV LLC has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.